Effects of clomipramine hydrochloride on heart rate and rhythm in healthy dogs

American Journal of Veterinary Research

Volumn 61, Issue 8, 2000, Pages 960-964

  Pouchelon, Jean Louis ^a   Martel, Eric ^b   Champeroux, Pascal ^b   Richard, Serge ^b   King, Jonathan N ^c  

^a Ecl Veterinaire de Maisons Alfort   (France)

^b Centre de Recherches Biologiques   (France)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART RATE; HEART RHYTHM; MALE; NONHUMAN; PSYCHOPHARMACOLOGY;

EID: 0033873767     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.960     Document Type: Article

References (31)

1. Trimble MR. Worldwide use of clomipramine. J Clin Psychiatry 1990;51:51-54.
2. McTavish D, Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 1990;39:136-153.
3. Glassman AH, Bigger JT. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981;38:815-820.
4. Leonard HL, Meyer MC, Swedo SE, et al. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry 1995;34:1460-1468.
5. Halper JP, Mann JJ. Cardiovascular effects of antidepressant medications. Br J Psychiatry 1988;3(suppl):87-98.
6. Warrington SJ, Padgham C, Lader M, The cardiovascular effects of antidepressants. Psychol Med Monogr 1989;16(suppl):3-40.
7. Beaumont G. Side-effects of toxicity of clomipramine. Br J Clin Pract 1979;3(Suppl):51-53.
8. Goldberger E, Rapoport JL. Canine acral lick dermatitis: response to the antiobsessional drug clomipramine. J Am Anim Hosp Assoc 1991;27:179-182.
9. Rapoport JL, Ryland DH, Kriete M. Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:517-521.
10. Mertens PA, Dodman NH. Drug treatment for canine acral lick dermatitis. Kleintierpraxis 1996;41:327-337.
11. Simpson B. Treatment of separation-related anxiety in dogs with domipramine. Results from a multicentre, blinded, placebo-controlled clinical trial, in Proceedings. First Int Conf Vet Behav Med, 1997;143-154.
12. Moon-Fanelli AA, Dodman NH. Description and development of compulsive tail chasing in terriers and response to clomipramine treatment. J Am Vet Med Assoc 1998;212: 1252-1257.
13. Shanley K, Overall K. Rational selection of antidepressants for behavioural conditions. Vet Forum 1995;12:30-34.
14. Simpson BS, Simpson DM. Antipsychotics and antidepressants: behavioural pharmacotherapy Part I. Compend Contin Educ Pract Vet 1996;18:1067-1081.
15. Hewson CJ, Conlon PD, Luescher UA, et al. The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine. J Vet Pharmacol Ther 1998;21:214-222.
16. King JN, Maurer MP, Hotz RP, et al. Pharmacokinetics of clomipramine in dogs following single-dose intravenous and oral administration. Am J Vet Res 2000;61:74-79
17. King JN, Maurer MP, Altman BO, et al. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration. Am J Vet Res 2000;61:80-85.
18. Johnsson G, Lundborg P, Welin-Fogelberg I. Interaction studies between three antidepressant drugs (chlorimipramine, imipramine and zimeldine) and noradrenaline, tyramine and vagal stimulation on the heart rate and blood pressure in dogs. Acta Pharmacol Toxicol (Copenhagen) 1979;45:192-197.
19. Cazes M, Witchitz S, Provost D, et al. Comparison of the minimal lethal doses, cardiac toxicities, and cardiodepressor effects of tricyclic antidepressants and UP 614-04, a potential antidepressant. Drug Dev Res 1983;3:17-27.
20. Hashimoto H, Nishimoto M, Ozaki T, et al. Comparison of the cardiac electrophysiologic effects of amitriptyline and clomipramine in the dog after myocardial infarction. Arch Int Pharmacodyn Ther 1990;304:181-195.
21. Jandhyala BS, Steenberg ML, Perel JM, et al. Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogs. Eur J Pharmacol 1977;42:403-410.
22. Lindbom LO, Malatry J, Hall H, et al. Cardiovascular and anticholinergic effects of zimelidine. Prog Neuropsychopharmacol Biol Psychiatry 1982;6:403-406.
23. Yokota S, Ishikura Y, Ono H. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine. Jpn J Pharmacol 1987;45:335-342.
24. Rubenson D, Griffin JC, Ford A, et al. Telemetry of electrophysiologic variables from conscious dogs: system design, validation and serial studies. Am Heart J 1984;107:90-96.
25. Detweiler DK. Electrocardiography in toxicological studies. In: Bishop SP, Kerns WD, eds. Comprehensive toxicology. 1st ed. Vol. 6. Amsterdam: Elsevier, 1997;95-115.
26. Sheline YI, Freedland KE, Carney RM. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am J Med 1997;102:54-59.
27. Steinberg MI, Smallwood JK, Holland DR, et al. Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs Toxicol Appl Pharmacol 1986;82:70-79.
28. Ellison JM, Milofsky JE, Ely E. Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry 1990;51: 385-386.
29. Benfield DP, Harries CM, Luscombe DK. Some pharmacological aspects of desmethylclomipramine. Postgrad Med J 1980;56(suppl):13-18.
30. Fuller RW, Holland DR, Yen TT. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats. Life Sci 1979;25: 1237-1242.
31. Glassman AH, Roose SP, Bigger JT. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993;269:2673-2675.